You May Have Heard of Semaglutide…
The once-a-week injectable GLP-1 receptor agonist that has taken the internet by storm. It helps to lower blood sugar levels by stimulating the production of insulin and slowing down the absorption of glucose in the gut. It is marketed under the brand name Ozempic® for Type-2 Diabetes, and most recently as Wegovy® for weight loss by the Novo Nordisk® company.
Touted as the solution for obesity by everyone from doctors to celebrity CEO, Elon Musk. But this fame has come at a cost, rising popularity has lead to shortages of Semaglutide across the country, and now regular people can’t get access to the lifesaving drug they rely upon, so is compounded Semaglutide legal?
Is Semaglutide Patented?
It is 100% true that Ozempic® and Wegovy® are patented drugs. Specifically, Novo Nordisk® owns the patent on the active pharmaceutical ingredient (API) in both Ozempic® and Wegovy®, which is Semaglutide. So, that must mean nobody else can make Semaglutide until the patent expires… right?
What is a Patented Drug?
A patented drug is a medication that is protected by a patent, which is a legal monopoly granted to the inventor or assignee of the drug. This means that only the patent holder is allowed to produce, sell, and distribute the drug for a certain period of time.
In the United States, the length of time that a drug patent lasts depends on the type of drug and when it was approved by the US Food and Drug Administration (FDA). Generally, drug patents last for 20 years from the date of filing. This isn’t always how long a patent lasts for though.
For example, if a drug is approved under the FDA’s Orphan Drug Act, the patent term may be extended by up to five years. This is because the Orphan Drug Act provides incentives for pharmaceutical companies to develop drugs for rare diseases, which are diseases that affect fewer than 200,000 people in the US. Additionally, if a drug is subject to FDA regulatory review, the patent term may be extended by up to five years to compensate for the time the drug company spent in the regulatory review process.
It’s also worth noting that, in some cases, a drug company may be able to extend the patent term of a drug by obtaining additional patents for new uses, formulations or methods of administration of the drug.
However, there are certain circumstances in which a patented drug may be compounded by third-party compounding pharmacies.
Is Compounded Semaglutide Legal? Yes!
One of the main reasons that a patented drug may be compounded is to address a shortage of the medication. A drug shortage can occur for a variety of reasons, such as production problems, manufacturing delays, or increased demand for the drug. In the case of Semaglutide, the drug shortage has been so severe that patients are unable to access the medication they need to manage their condition.
When a drug is on the FDA Shortage List, the FDA may allow compounding pharmacies to produce a compounded version of the drug to help alleviate the shortage.
The FDA has a list of drugs that are in shortage, which is updated regularly.
As of January 22nd, 2023 (01/22/2023), Semaglutide is listed as being in shortage according to the FDA.
The FDA must first determine that there is a shortage of the drug and that there are no suitable alternatives available. Additionally, the FDA must also ensure that the compounded version of the drug is safe and effective, and that it is being produced under appropriate conditions. This can be met by ensuring the drug is produced exclusively in an FDA-licensed compounding pharmacy.
Other Reasons for Compounding Patented Drugs
Another reason that a patented drug may be compounded is to provide a customized medication for a specific patient. For example, a patient may have an allergy to an ingredient in a drug, or they may require a different dosage than what is available on the market. In such cases, a compounding pharmacy may be able to create a customized version of the drug that is tailored to the patient’s needs.
Additionally, if a specific drug is not yet available in a specific form, such as a liquid form for pediatric patients or a long-acting form for some chronic conditions, compounding pharmacies may be able to create these formulations. This can be done by compounding a drug that is already FDA-approved but not available in the desired form.
The Future of Compounded Semaglutide
There is currently no known end-date for the Semaglutide shortage. When the shortage does end, compounding pharmacies will be prohibited from producing Semaglutide as it relates to the drug shortage. Compounding pharmacies may still be allowed to create customized dosage forms or alternative delivery methods of Semaglutide based on the specific needs of individual patients.
Compounding pharmacies play a vital role in the United States healthcare system, and their services should be valued and supported.
Do you need Semaglutide?
If you need compounded Semaglutide, Henry Meds may be able to help. We have created a platform that connects patients, providers, and compounding pharmacists in one place so that everyone can afford the lifesaving medications they need.
Henry Makes Treatment as Easy as 1 – 2 – 3
Only $198 per month – No Hidden Fees
1. Schedule Your Appointment
2. Talk to Your New Clinician
3. Receive Medication
Henry Meds is not affiliated with the Novo Nordisk® company. Medications offered are compounded Semaglutide. Ozempic® and Wegovy® are patented medications owned by the Novo Nordisk® company. We imply no affiliation or endorsement with the above mentioned brands and companies.